Clouds of Care proudly announces the successful closure of our funding round. We have secured €5 million, highlighting strong investor confidence and support for our mission to improve CNS clinical development through Digital Health Technologies and advanced data analytics.
We are immensley proud and excited to have two experienced life sciences professionals join our board; Michel Vounatsos, former CEO of biotech company Biogen, is welcomed as chairman, and Yacine Hadjiat, global HealthTech expert and senior pharma executive, will join the board as an independent director.
"Pharma no longer just needs best-in-class tools; they want platforms that promote standardization across these tools. This is exactly what Clouds of Care aims to achieve within the market for neurological disorders," said Nicolas Roberti de Winghe, partner at TCD Capital. Together with the Flanders Future Tech Fund and White Fund, they led the funding round.
We will use the funding driving positive change in CNS clinical development by investing in our technological infrastructure, expanding our team of experts, and deepening our research and development efforts - ultimately improving the lives of patients worldwide.
